Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2002
10/24/2002US20020156256 Nucleic acid and amino acid sequences of a novel H-rev107-like protein for use in diagnosis, prevention, and treatment of cancer and autoimmune disorders
10/24/2002US20020156254 Nucleotide sequences coding polypeptide for use in the treatment of stress, diabetes, cancer, inflammatory and cardiovascular disorders
10/24/2002US20020156252 Novel Stra6 polypeptides
10/24/2002US20020156251 Fusion protein for use in the treatment and prevention of viral diseases
10/24/2002US20020156248 Novel method for targeted delivery of nucleic acids
10/24/2002US20020156246 15625 receptor, a novel G-protein coupled receptor
10/24/2002US20020156244 Adipocyte complement related protein zacrp13
10/24/2002US20020156243 Adipocyte-specific protein homologs
10/24/2002US20020156241 Leukotriene receptor
10/24/2002US20020156240 Alpha-agarase and process for producing the same
10/24/2002US20020156239 Tryrosine kinases receptor protein for use in the prevention and treatment of of nervous system, inflammatory and tumor defects
10/24/2002US20020156234 Obtaining insulin precursors; generate suspension of insulin and cysteine hydrochloride, heat, recover insulin precursors
10/24/2002US20020156123 Novel pharmaceutical compositions for modulating angiogenesis
10/24/2002US20020156110 Anticancer, antiproliferative and antiarthritic agents
10/24/2002US20020156049 Highly packed polycationic ammonium, sulfonium and phosphonium lipids
10/24/2002US20020156042 Human suppressor tRNA oligonucleotides and methods of use for same
10/24/2002US20020156041 Non-squamous epithelium-specific transcription
10/24/2002US20020156040 Antisense oligonucleotides that bind to the enzyme's start codon; inhibiting enzymes such as superoxide dismutase
10/24/2002US20020156036 Expression vector encoding a fusion protein with segments of a region which binds to an epitope or fragment and fragment or whole proteins that can cross the blood brain barrier
10/24/2002US20020156035 NET-4 is a member of the tetraspan transmembrane receptor family; antisense molecules, ribozymes, antibodies and antibody fragments for reductin NET-4 gene expression or activity; antitumor agents
10/24/2002US20020156031 A DNA segment comprising a protein coding region encoding an Osterix polypeptide; gene therapy; osteoporosis; recombinant Osterix polypeptide
10/24/2002US20020156017 Antimicrobial peptides and methods of use thereof
10/24/2002US20020156013 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
10/24/2002US20020156007 Apolipoprotein analogues
10/24/2002US20020156005 m32404, a novel human trypsin and uses thereof
10/24/2002US20020156001 Novel fibroblast growth factor ( FGF23) and methods for use
10/24/2002US20020156000 Inhibiting NF-kappa B-dependent target gene expression in a cell.
10/24/2002US20020155998 Erythropoietin analog-human serum albumin fusion
10/24/2002US20020155989 Protein nucleic acid molecules
10/24/2002US20020155987 Isolated endostatin, especially approximately 20 kDa and corresponds to a C-terminal fragment of collagen type XVIII
10/24/2002US20020155612 Generation of preferential protein in sample; obtain bacillus, transform, express vector, recover protein
10/24/2002US20020155611 Permeabilizing cells; obtain cells, expose to electric pulse, monitor fluid flow through membranes
10/24/2002US20020155610 High-efficiency wild-type-free AAV helper functions
10/24/2002US20020155609 Monocyte-specific particulate delivery vehicle
10/24/2002US20020155608 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions
10/24/2002US20020155607 Multifunctional molecular complexes for gene transfer to cells
10/24/2002US20020155606 Method for regulating gene expression
10/24/2002US20020155605 Expression vector for use as tool in controlling gene expression in plants
10/24/2002US20020155604 Compositions and methods for regulating lymphocyte activation
10/24/2002US20020155602 Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors
10/24/2002US20020155601 Method for producing a population of homozygous stem cells having a pre-selected immunotype and/or genotype, cells suitable for transplant derived therefrom, and materials and methods using same
10/24/2002US20020155597 In vivo production and delivery of erthropoietin or insulinotropin for gene therapy
10/24/2002US20020155596 Recombinant vaccinia virus incorporated with gene coding glutamic acid decarboxylase and vaccine for preventing type 1 diabetes mellitus comprising the same
10/24/2002US20020155582 Genetically engineered ciral particles for use in the prevention of viral diseases
10/24/2002US20020155581 Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
10/24/2002US20020155580 Recombinant aav vectors for gene therapy of hemophilia a
10/24/2002US20020155578 Streptavidin-binding peptides and uses thereof
10/24/2002US20020155577 Compound for use in the treatment of parkinson's disease
10/24/2002US20020155573 Cod uracil-DNA glycosylase, gene coding therefore, recombinant DNA containing said gene or operative parts thereof, a method for preparing said protein and the use of said protein or said operative parts thereof in monitoring or controlling PCR
10/24/2002US20020155572 Peptide for use in diagnosis and treatment of alzheimier's disease
10/24/2002US20020155571 Triazine degrading enzymes
10/24/2002US20020155570 Nucleotide sequences coding polypeptide for use in the prevention, treatment of cancer
10/24/2002US20020155569 Regulation of gene expression through manipulation of mRNA splicing and its uses
10/24/2002US20020155564 Cloning of a high growth gene
10/24/2002US20020155563 Nucleotide sequences coiding polypeptide for use in the diagnosis, prevention and treatment of tumors and immunological defects
10/24/2002US20020155562 Glutathionylspermidine synthetase and processes for recovery and use thereof
10/24/2002US20020155557 Nucleotide sequences which code for the rpsL gene
10/24/2002US20020155554 Nucleotide sequences coding polypeptide for use in generation of amino acids for use in human and animal medicines and nutrients
10/24/2002US20020155553 Human vesicle binding protein
10/24/2002US20020155552 "prionins", highly specific markers for noninvasive pre-symptomatic detection of tse diseases, and targets for therapeutic reagents to prevent and control tse diseases in animals and humans
10/24/2002US20020155547 Polypeptide for use in the treatment of cancer, hepatitis, multiple sclerosis, fibrosis, inflammatory or autoimmune diseases, cancers and viral diseases
10/24/2002US20020155546 Adipocyte complement related protein ZACRP12
10/24/2002US20020155545 Chemokines expressed in pancreas
10/24/2002US20020155544 Treatment of diabetes with synthetic beta cells
10/24/2002US20020155540 Inhibiting gene expression in cells; obtain cells, transform with expression vector, propagate, monitor cells for decrease in gene expression
10/24/2002US20020155539 Calcium channel polynucleotides, polypeptides, and antibodies
10/24/2002US20020155537 Method for making heteromultimeric polypeptides
10/24/2002US20020155536 Expression cloning in filamentous fungi
10/24/2002US20020155534 SBHWSB2: a new member of the WD40 SOCS box family
10/24/2002US20020155532 Method of producing biologically active human acidic fibroblast growth factor and its use in promotiong angiogenesis
10/24/2002US20020155531 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
10/24/2002US20020155530 Expression vector with dual control of replication and transcription
10/24/2002US20020155529 Viral vectors having reduced virulence
10/24/2002US20020155528 Regulation of human CysLT2-like GPCR protein
10/24/2002US20020155527 Nucleotide sequences coding membrane protein for use in the treatment of tumors
10/24/2002US20020155525 Expression vector for use in generation of preferential polypeptides in culture
10/24/2002US20020155521 Amplifying carbon flow in preferential metabolic process; obtain cell of preferential genotype, propagate with preferental carbohydrate, monitor carbon transport
10/24/2002US20020155520 Coating particle with dye; contacting cell; releasing dye
10/24/2002US20020155519 Human blood bacterium
10/24/2002US20020155517 Detecting modulator of microorganism gene expression; obtain fungus, incubate with modulator, monitor expression of preferential gene, decreaseed expression of gene indicates modulator
10/24/2002US20020155510 Dendritic cell-specific antibodies
10/24/2002US20020155509 Retentate chromatography and protein chip arrays with applications in biology
10/24/2002US20020155508 Linear and circular expression elements
10/24/2002US20020155502 Detecting modulators with amplified binding activity; obtain expression vector containing target protein, incubate with modulator, monitor expression of reporter molecule, culture cell expressing reporter molecule
10/24/2002US20020155500 Detecting modulators of receptor binding activity; obtain sample containing receptor protein, incubate with modulator, monitor and evaluate protein binding
10/24/2002US20020155499 Nucleotide sequences coding polypeptides for use in the treatment of tumors, autoimmune inflammatory and Paget's disease
10/24/2002US20020155498 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
10/24/2002US20020155497 Nucleotide sequences coding polypeptide for use in the treatment of Alzheimer's, myasthenia gravis, and vision diseases
10/24/2002US20020155489 Generating libraries of nucleotide sequence clones; obtain cells, extract nucleotide sequences, digest sequence, incubate with expression vector, digest, ligate, transform cell, propgate, recover clonal library
10/24/2002US20020155484 Oligonucleotide for use as tool in the detection of preferential compounds in solution
10/24/2002US20020155479 Expression cloning method
10/24/2002US20020155477 Gene detection system, gene detection device comprising same, detection method, and gene detecting chip
10/24/2002US20020155475 Method for processing a nucleic acid sample by oscillating a cartridge, a system and a cartridge for performing such a method
10/24/2002US20020155474 Methods and reagents for detecting increased risk of developing an inflammatory disorder
10/24/2002US20020155470 Intercalation compound for use in the diagnosis and detection of genetic disorders
10/24/2002US20020155464 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention, classification, imaging and treatment of cancer
10/24/2002US20020155455 Marker compound for use as visualization tool in genetic engineering
10/24/2002US20020155454 Miniribozymes active at low magnesium ion concentrations
10/24/2002US20020155453 Method for generating diversity
10/24/2002US20020155452 Fusion of jAZF1 and jjAZ1 genes in endometrial stromal tumors